FrancophonIA/ELRC3.0 huggingface dataset:
English: Sodium Valproate 500mg
Estonian: Naatriumvalproaat 500 mg
English: Sodium Valproate 200mg
Estonian: Naatriumvalproaat 200 mg
English: Sodium Valproate 500mg Container
Estonian: Naatriumvalproaat 500 mg konteiner
English: Valproate Retard Mylan Sodium Valproate 500mg Tablet
Estonian: Valproate Retard Mylan Naatriumvalproaat 500 mg tablett
English: Austria sanofi-aventis GmbH Depakine Chronosphere Valproic Acid 145.14mg Sachet, Sodium
Estonian: Austria sanofi-aventis GmbH Depakine Chronosphere Valproehape 145,14 mg kotike,
English: Espa-Valept Retard Sodium Valproate 300mg Tablet
Estonian: Espa-Valept Retard Naatriumvalproaat 300 mg tablett
English: Valproate Retard Mylan Sodium Valproate 300mg Tablet
Estonian: Valproate Retard Mylan Naatriumvalproaat 300 mg tablett
English: Depakine Chronosphere Valproic Acid 217.75mg Sachet, Sodium
Estonian: Depakine Chronosphere Valproehape 217,75 mg kotike,
English: Sodium Valproate 400mg Container
Estonian: Naatriumvalproaat 400 mg konteiner
English: Sanofi-Aventis Aebe Depakine Chronosphere Valproic Acid 29.03mg Sachet, Sodium
Estonian: Sanofi-Aventis Aebe Depakine Chronosphere Valproehape 29,03 mg kotike,
English: Austria sanofi-aventis GmbH Depakine Chronosphere Valproic Acid 72.61mg Sachet, Sodium
Estonian: Austria sanofi-aventis GmbH Depakine Chronosphere Valproehape 72,61 mg kotike,
English: Sanofi-Aventis Aebe Depakine Chronosphere Valproic Acid 290.27mg Sachet, Sodium
Estonian: Sanofi-Aventis Aebe Depakine Chronosphere Valproehape 290,27 mg kotike,
English: Sanofi-Aventis Aebe Depakine Chronosphere Valproic Acid 72.61mg Sachet, Sodium
Estonian: Sanofi-Aventis Aebe Depakine Chronosphere Valproehape 72,61 mg kotike,
English: Valproat Neuraxpharm Sodium Valproate 60mg/Ml
Estonian: Valproat Neuraxpharm Naatriumvalproaat 60 mg/ml
English: Valproate Magnesium 500mg Tablet
Estonian: Magneesiumvalproaat 500 mg tablett
English: Sodium Valproate 300mg Capsule
Estonian: Naatriumvalproaat 300 mg kapsel
English: Sodium Valproate 150mg Capsule
Estonian: Naatriumvalproaat 150 mg kapsel
English: Valproate Semisodium 250mg Tablet
Estonian: Seminaatriumvalproaat 250 mg tablett
English: Valproate 333mg Tablet
Estonian: 333,3 mg tablett
English: United Kingdom Aventis Pharma Ltd Epilim Chronosphere Valproic Acid 72.61mg Sachet, Sodium
Estonian: Aventis Pharma Ltd Epilim Chronosphere Valproehape 72,61 mg kotike,
English: Depakine Chronosphere Valproic Acid 290.27mg Sachet, Sodium
Estonian: Depakine Chronosphere Valproehape 290,27 mg kotike,
English: Austria sanofi-aventis GmbH Depakine Chronosphere Valproic Acid 14.51mg Sachet, Sodium
Estonian: Austria sanofi-aventis GmbH Depakine Chronosphere Valproehape 14,51 mg kotike,
English: United Kingdom Aventis Pharma Ltd Epilim Chronosphere Valproic Acid 29.03mg Sachet, Sodium
Estonian: Aventis Pharma Ltd Epilim Chronosphere Valproehape 29,03 mg kotike,
English: Sodium Valproate 300mg
Estonian: Naatriumvalproaat 300 mg
English: United Kingdom Aventis Pharma Ltd Epilim Chronosphere Valproic Acid 217.75mg Sachet, Sodium
Estonian: Aventis Pharma Ltd Epilim Chronosphere Valproehape 217,75 mg kotike,
English: United Kingdom Aventis Pharma Ltd Epilim Chronosphere Valproic Acid 145.14mg Sachet, Sodium
Estonian: Aventis Pharma Ltd Epilim Chronosphere Valproehape 145,14 mg kotike,
English: Valproate Magnesium 200mg Tablet
Estonian: Magneesiumvalproaat 200 mg tablett
English: Epilim Chronosphere Valproic Acid 29.03mg Sachet, Sodium
Estonian: Epilim Chronosphere Valproehape 29,03 mg kotike,
English: Sodium Valproate 500mg Capsule
Estonian: Naatriumvalproaat 500 mg kapsel
English: Modified-Release Capsule, Hard
Estonian: Toimeainet modifitseeritult vabastav kõvakapsel
English: Epilim Chronosphere Valproic Acid 72.61mg Sachet, Sodium
Estonian: Epilim Chronosphere Valproehape 72,61 mg kotike,
English: United Kingdom Aventis Pharma Ltd Epilim Chronosphere Valproic Acid 290.27mg Sachet, Sodium
Estonian: Aventis Pharma Ltd Epilim Chronosphere Valproehape 290,27 mg kotike,
English: United Kingdom Aventis Pharma Ltd Epilim Chronosphere Valproic Acid 14.51mg Sachet, Sodium
Estonian: Aventis Pharma Ltd Epilim Chronosphere Valproehape 14,51 mg kotike,
English: Valproat Neuraxpharm Sodium Valproate 300mg/Ml
Estonian: Valproat Neuraxpharm Naatriumvalproaat 300 mg/ml
English: ácido Valpróico Sandoz Sodium Valproate 500mg Tablet
Estonian: ácido Valpróico Sandoz Naatriumvalproaat 500 mg tablett
English: ácido Valpróico Sandoz Sodium Valproate 300mg Tablet
Estonian: ácido Valpróico Sandoz Naatriumvalproaat 300 mg tablett
English: Depakine Chronosphere Valproic Acid 29.03mg Sachet, Sodium
Estonian: Depakine Chronosphere Valproehape 29,03 mg kotike,
English: Depakine Chronosphere Valproic Acid 14.51mg Sachet, Sodium
Estonian: Depakine Chronosphere Valproehape 14,51 mg kotike,
English: Valproate 200mg Tablet
Estonian: Valpromiid 300 mg tablett
English: Depakine Chronosphere Valproic Acid 145.14mg Sachet, Sodium
Estonian: Depakine Chronosphere Valproehape 145,14 mg kotike,
English: Depakine Chronosphere Valproic Acid 72.61mg Sachet, Sodium
Estonian: Depakine Chronosphere Valproehape 72,61 mg kotike,
English: Acido Valproico Sandoz Sodium Valproate 500mg Tablet
Estonian: Acido Valproico Sandoz Naatriumvalproaat 500 mg tablett
English: Acido Valproico Sandoz Sodium Valproate 300mg Tablet
Estonian: Acido Valproico Sandoz Naatriumvalproaat 300 mg tablett
English: Epilim Chronosphere Valproic Acid 145.14mg Sachet, Sodium
Estonian: Epilim Chronosphere Valproehape 145,14 mg kotike,
English: Valproate Retard Eg Valproic Acid 87mg Tablet, Sodium
Estonian: Valproate Retard Eg Valproehape 87 mg tablett,
English: Sodium Valproate 1000mg Sachet
Estonian: Naatriumvalproaat 1000 mg kotike
English: Valproát Chrono Sandoz Sodium Valproate 500mg Tablet
Estonian: Valproát Chrono Sandoz Naatriumvalproaat 500 mg tablett
English: Valproat Chrono Sandoz Sodium Valproate 500mg Tablet
Estonian: Valproat Chrono Sandoz Naatriumvalproaat 500 mg tablett
English: Valproat 1 A Pharma Sodium Valproate 150mg Tablet
Estonian: Valproat 1 A Pharma Naatriumvalproaat 150 mg tablett
English: Valproat Neuraxpharm Sodium Valproate 600mg Units
Estonian: Valproat Neuraxpharm Naatriumvalproaat 600 mg ühikut
English: Valproat Chrono Sandoz Sodium Valproate 300mg Tablet
Estonian: Valproat Chrono Sandoz Naatriumvalproaat 300 mg tablett
English: Valproát Chrono Sandoz Sodium Valproate 300mg Tablet
Estonian: Valproát Chrono Sandoz Naatriumvalproaat 300 mg tablett
English: Valproat Neuraxpharm Sodium Valproate 150mg Units
Estonian: Valproat Neuraxpharm Naatriumvalproaat 150 mg ühikut
English: Valproic Acid 72.61mg Sachet, Sodium Valproate 166.76mg Sachet
Estonian: Naatriumvalproaat 166,76 mg kotike
English: Valproat 1 A Pharma Sodium Valproate 300mg Tablet
Estonian: Valproat 1 A Pharma Naatriumvalproaat 300 mg tablett
English: Valproat 1 A Pharma Sodium Valproate 500mg Tablet
Estonian: Valproat 1 A Pharma Naatriumvalproaat 500 mg tablett
English: Valproate Retard Eg Valproic Acid 145mg Tablet, Sodium
Estonian: Valproate Retard Eg Valproehape 145 mg tablett,
English: Valproat 1 A Pharma Sodium Valproate 600mg Tablet
Estonian: Valproat 1 A Pharma Naatriumvalproaat 600 mg tablett
English: Valproic Acid 29.03mg Sachet, Sodium Valproate 66.66mg Sachet
Estonian: Naatriumvalproaat 66,66 mg kotike
English: Valproic Acid 290.27mg Sachet, Sodium Valproate 666.6mg Sachet
Estonian: Naatriumvalproaat 666,6 mg kotike
English: Valproat Neuraxpharm Sodium Valproate 500mg Units
Estonian: Valproat Neuraxpharm Naatriumvalproaat 500 mg ühikut
English: Valproat Neuraxpharm Sodium Valproate 300mg Units
Estonian: Valproat Neuraxpharm Naatriumvalproaat 300 mg ühikut
English: Sodium Valproate Teva Sodium Valproate 200mg Tablet
Estonian: Naatriumvalproaat Teva Naatriumvalproaat 200 mg tablett
English: Valpromide 300mg Tablet
Estonian: Seminaatriumvalproaat 500 mg tablett
English: Sodium Valproate 300mg Suppository
Estonian: Naatriumvalproaat 300 mg rektaalsuposiit
English: Oral Drops, Solution Oral Use
Estonian: Suukaudsed tilgad, lahus
English: What measures are being taken to ensure the safe and effective use of Ucedane?
Estonian: Mis meetmed võetakse, et tagada Ucedane ohutu ja efektiivne kasutamine?
English: Treatment may be started as early as the first day of life and the medicine is used for the patient's whole life.
Estonian: Ravi võib alustada esimesel elupäeval ja ravimit kasutatakse kogu elu.
English: The initial daily dose of Ucedane should be 100 mg per kilogram body weight, but up to 250 mg/kg can be used if necessary.
Estonian: Ucedane algannus on 100 mg kehakaalu kg kohta ööpäevas, kuid vajaduse korral tohib kasutada kuni 250 mg/kg.
English: The full EPAR for Ucedane can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Ucedane kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: What is Ucedane and what is it used for?
Estonian: Mis on Ucedane ja milleks seda kasutatakse?
English: Ucedane is available as dispersible tablets (200 mg) that are to be dispersed (mixed) in a small amount of water.
Estonian: Ucedanet turustatakse dispergeeruvate tablettidena (200 mg), mis dispergeeritakse (segatakse) väikeses koguses vees.
English: As for every medicine, the company provided studies on the quality of Ucedane.
Estonian: Nagu iga ravimi korral, esitas ettevõte uuringud Ucedane kvaliteedi kohta.
English: Ucedane carglumic acid
Estonian: Ucedane kargluumhape
English: The Committee recommended that Ucedane be approved for use in the EU.
Estonian: Komitee soovitas Ucedane kasutamise Euroopa Liidus heaks kiita.
English: Why is Ucedane approved?
Estonian: Miks Ucedane heaks kiideti?
English: The dose should then be adjusted to maintain normal blood ammonia levels.
Estonian: Annust võib seejärel kohandada, et säilitada vere normaalne ammoniaagisisaldus.
English: It is not intended to provide practical advice on how to use Ucedane.
Estonian: Hindamisaruandes ei anta Ucedane kasutamise praktilisi nõuandeid.
English: Ucedane therefore helps break down ammonia, reducing ammonia blood levels and its toxic effects.
Estonian: Seega aitab Ucedane lagundada ammoniaaki ja vähendab ammoniaagi sisaldust veres ning selle mürgist toimet.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Ucedane has been shown to have comparable quality and to be bioequivalent to Carbaglu.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud ravimi Ucedane võrreldav kvaliteet ja bioekvivalentsus ravimiga Carbaglu.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ucedane have been included in the summary of product characteristics and the package leaflet.
Estonian: Ucedane ohutu ja efektiivse kasutamise soovitused ja ettevaatusmeetmed tervishoiutöötajatele ja patsientidele on lisatud ravimi omaduste kokkuvõttesse ja pakendi infolehele.
English: Patients with this lifelong disease lack a liver enzyme called NAGS, which normally helps to break down ammonia.
Estonian: Selle eluaegse haigusega patsientidel puudub maksaensüüm N-atsetüülglutamaadi süntaas, mis aitab tavaliselt ammoniaaki lagundada.
English: Because Ucedane is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Estonian: Et Ucedane on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: Other information about Ucedane
Estonian: Muu teave Ucedane kohta
English: This means that Ucedane contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Carbaglu.
Estonian: See tähendab, et Ucedane sisaldab sama toimeainet ja toimib samal viisil kui võrdlusravim Carbaglu, millel juba on Euroopa Liidus müügiluba.
English: If the enzyme is not present, ammonia cannot be broken down and it builds up in the blood.
Estonian: Kui see ensüüm puudub, siis ammoniaak ei lagune ja koguneb verre.
English: Therefore, the CHMP's view was that, as for Carbaglu, the benefit outweighs the identified risk.
Estonian: Seetõttu on inimravimite komitee arvamusel, et nagu ka Carbaglu korral, ületab ravimi Ucedane kasulikkus sellega kaasnevad riskid.
English: Studies on the benefits and risks of the active substance in the approved use have already been carried out with the reference medicine, Carbaglu, and do not need to be repeated for Ucedane.
Estonian: Võrdlusravimiga Carbaglu on juba tehtud toimeaine heakskiidetud kasutamisviiside kasulikkuse ja riski uuringud ning neid ei ole vaja ravimiga Ucedane korrata.
English: For practical information about using Ucedane, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate Ucedane kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: This is a summary of the European public assessment report (EPAR) for Ucedane.
Estonian: See on ravimi Ucedane Euroopa avaliku hindamisaruande kokkuvõte.
English: How is Ucedane used?
Estonian: Kuidas Ucedanet kasutatakse?
English: Ucedane is a medicine used for the treatment of hyperammonaemia (high blood levels of ammonia) in patients with N-acetylglutamate synthase (NAGS) deficiency.
Estonian: Ucedane on ravim, mida kasutatakse hüperammoneemia (vere suur ammoniaagisisaldus) raviks N-atsetüülglutamaadi süntaasi (NAGS) vaegusega patsientidel.
English: For more information about treatment with Ucedane, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Ucedanega toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: The active substance in Ucedane, carglumic acid, is very similar in structure to N-acetylglutamate, which activates an enzyme that breaks down ammonia.
Estonian: Ucedane toimeaine kargluumhape on struktuurilt väga sarnane N-atsetüülglutamaadiga, mis aktiveerib ammoniaaki lagundavat ensüümi.
English: The medicine can only be obtained with a prescription and treatment should be started by a doctor who has experience in treating patients with metabolic diseases such as NAGS deficiency.
Estonian: Ucedane on retseptiravim ja ravi tohib alustada üksnes ainevahetushaigustega (nagu NAGS-i vaegus) patsientide ravis kogenud arst.
English: What are the benefits and risks of Ucedane?
Estonian: Milles seisneb Ucedane kasulikkus ja mis riskid ravimiga kaasnevad?
English: When ammonia builds up in the blood, it is toxic to the body, especially the brain.
Estonian: Verre kogunenud ammoniaak on organismile, eriti ajule mürgine.
English: Ucedane contains the active substance carglumic acid and is a ‘generic medicine'.
Estonian: Ucedane sisaldab toimeainena kargluumhapet ja see on geneeriline ravim.
English: How does Ucedane work?
Estonian: Kuidas Ucedane toimib?
English: How has Ucedane been studied?
Estonian: Kuidas Ucedanet uuriti?
English: EU/1/04/273/001 Lysodren
Estonian: EU/1/04/273/001
English: Invented name Strength Pharmaceutical form Route of administration Packaging
Estonian: Müügiloa nr Euroopa Liidus Ravimpreparaadi nimetus Tugevus Ravimvorm Manustamisviis Pakend
English: 500 mg
Estonian: 500 mg Tablett
English: Date of first authorisation: 09 November 2015
Estonian: Esmase müügiloa väljastamise kuupäev: 9. november 2015
English: Additional risk minimisation measures
Estonian: Täiendavad riski minimeerimise meetmed
English: These effects were sustained in longer-term studies.
Estonian: Need toimed püsisid pikemaajalistes uuringutes.
English: More information is given below under ‘Other medicines and Edistride'.
Estonian: Rohkem teavet on esitatud allpool lõigus ‘Muud ravimid ja Edistride';
English: The patient may need to take extra insulin and drink water.
Estonian: Patsient võib vajada lisakogust insuliini ja juua vett.
English: Edistride is used in adult patients (aged 18 years and older).
Estonian: Edistridet kasutatakse täiskasvanud patsientidel (18-aastased ja vanemad).
English: Edistride is not recommended for children and adolescents under 18 years of age, because it has not been studied in these patients.
Estonian: Edistridet ei soovitata lastele ega alla 18-aastastele noorukitele, kuna seda ravimit ei ole neil patsientidel uuritud.
English: Measure your ketone levels again in 2 hours.
Estonian: Mõõtke oma ketokehade sisaldust uuesti 2 tunni pärast.
English: The recommended actions are listed in Table 1.
Estonian: Soovitatavad meetmed on loetletud tabelis 1.
English: See “Description of selected adverse reactions” and section 4.4.
Estonian: Vt lõiku „Valitud kõrvaltoimete kirjeldus“ ja lõiku 4.4.
English: Edistride can be taken orally once daily at any time of day with or without food.
Estonian: Edistridet võib võtta suukaudselt üks kord ööpäevas suvalisel ajal kas toiduga või ilma.
English: • For renal function with GFR < 60 mL/min, at least 2 to 4 times per year.
Estonian: • neerufunktsioon, mille puhul GFR on < 60 ml/min, vähemalt kaks kuni neli korda aastas.
English: Patients should consider monitoring ketones levels three to four hours after changing pump materials.
Estonian: Patsiendid peavad kaaluma ketokehade sisalduse kontrollimist kolme kuni nelja tunni möödumisel pumba materjalide vahetamisest.
English: Obligation to conduct post-authorisation measures: The MAH shall complete, within the stated timeframe, the below measures: Description
Estonian: Kohustus võtta loa andmise järgseid meetmeid: Müügiloa hoidja võtab kehtestatud ajavahemiku jooksul järgmised meetmed: Kirjeldus
English: If you have type 2 diabetes, it can also help prevent heart disease.
Estonian: Kui teil on 2. tüüpi suhkurtõbi, võib see samuti aidata ennetada südamehaigust.
English: This may occur regardless of blood sugar level.
Estonian: See võib tekkida sõltumata veresuhkru sisaldusest.
English: Diet and exercise can help your body use its blood sugar better.
Estonian: Dieet ja füüsiline koormus võivad aidata teie kehal veresuhkrut paremini kasutada.
English: • Edistride is used together with insulin.
Estonian: • Edistridet kasutatakse koos insuliiniga.
English: Your doctor may decide to temporarily or permanently stop your treatment with Edistride.
Estonian: Teie arst võib otsustada ajutiselt või täielikult lõpetada ravi Edistridega.
English: The recommended actions are listed in Table 1 (see section 4.2).
Estonian: Soovitatavad meetmed on loetletud tabelis 1 (vt lõik 4.2).
English: • If it is 12 hours or more until your next dose, take a dose of Edistride as soon as you remember.
Estonian: • Kui teie järgmise annuseni on jäänud 12 või rohkem tundi, siis võtke Edistride annus niipea, kui see teile meenub.
English: • Summary of the recommendations for patients, particularly regarding blood ketone measurement and managing sick days.
Estonian: • Patsientidele mõeldud soovituste kokkuvõte, mis puudutab eelkõige ketokehade sisalduse mõõtmist verest ja haiguspäevadega toimetulemist.
English: Ketone levels should be also checked in situations that may predispose to or increase risk of DKA.
Estonian: Ketokehade sisaldust tuleb kontrollida ka olukordades, mis võivad DKA teket soodustada või selle tekkeriski suurendada.
English: glimepiride 4 mg/day;
Estonian: Glimepiriid 4 mg/ööpäevas;
English: See corresponding subsection below for additional information.
Estonian: Lisateabeks vt vastavat alalõiku allpool.
English: • It should be ensured that ketone levels are normal.
Estonian: • Veenduge, et ketokehade sisaldus on normaalne.
English: The patient alert card should contain the following key elements:
Estonian: Patsiendi hoiatuskaart peab sisaldama järgmisi põhielemente.
English: Do not drive or use any tools or machines, if you feel dizzy taking Edistride.
Estonian: Ärge juhtige autot ega kasutage tööriistu ega masinaid, kui te tunnete peapööritust Edistride kasutamisel.
English: Increased creatinine
Estonian: Kreatiniinisisalduse suurenemine
English: Study MB102229
Estonian: Uuring MB102229
English: Frequency categories are defined according to the following convention: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), and not known (cannot be estimated from the available data).
Estonian: Esinemissageduse kategooriad on määratletud vastavalt järgmisele tavale: väga sage (≥ 1/10), sage (≥ 1/100 kuni < 1/10), aeg-ajalt (≥ 1/1 000 kuni < 1/100), harv (≥ 10 000 kuni < 1/1 000), väga harv (< 1/10 000) ja teadmata (ei saa olemasolevate andmete põhjal hinnata).
English: Study MB102230
Estonian: Uuring MB102230
English: The MAH shall ensure that in each Member State where dapagliflozin is marketed for type 1 diabetes, all healthcare professionals and patients/carers who are expected to prescribe, dispense or use the product have access to:
Estonian: Müügloa hoidja peab tagama, et igas liikmesriigis, kus 1. tüüpi diabeedi raviks turustatakse dapagliflosiini, peab kõigil tervishoiutöötajatel ja patsientidel/hooldajatel, kes kas kirjutavad välja, väljastavad või kasutavad seda ravimit, olema juurdepääs järgmistele:
English: Type 1 diabetes: Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Estonian: 1. tüüpi diabeet: piiratud tingimustel väljastatav retseptiravim (vt I lisa: Ravimi omaduste kokkuvõte, lõik 4.2).
English: Throughout the study, insulin dose was adjusted as deemed appropriate.
Estonian: Kogu uuringu vältel kohandati insuliini annust vajaduse järgi.
English: Diabetic ketoacidosis b,i,k
Estonian: Diabeetiline ketoatsidoos b,i,
English: • Signs/symptoms of DKA - if not adequately managed DKA can be severe and fatal.
Estonian: • DKA nähud/sümptomid - ebapiisava ravi korral võib DKA osutuda tõsiseks ja surmavaks.
English: Ketone levels should be measured again after two hours.
Estonian: Ketokehade sisaldust tuleb kahe tunni pärast uuesti mõõta.
English: • The Patient Alert Card should be presented to any HCP consulted.
Estonian: • Patsiendi hoiatuskaarti tuleb näidata igale konsulteerivale tervishoiutöötajale.
English: If Fournier's gangrene is suspected, Forxiga should be discontinued and prompt treatment (including antibiotics and surgical debridement) should be instituted.
Estonian: Fournier' gangreeni kahtluse korral tuleb Edisride võtmine lõpetada ja alustada viivitamata ravi (sh antibiootikumravi ja kirurgiline puhastamine).
English: DPP-4 Inhibitor (sitagliptin 2) ± Metformin
Estonian: DPP-4 inhibiitor (sitagliptiin metformiin
English: • awakening from sleep at night to pass urine
Estonian: • öine ärkamine urineerimisvajaduse tõttu
English: If you are taking Edistride for type 1 diabetes, it is important that you keep using insulin.
Estonian: Kui te võtate Edistridet 1. tüüpi suhkurtõve raviks, siis on oluline, et jätkaksite insuliini kasutamist.
English: The increases in creatinine were generally transient during continuous treatment or reversible after discontinuation of treatment.
Estonian: Kreatiniini sisalduse suurenemine möödus tavaliselt edasise ravi käigus või kadus pärast ravi katkestamist.
English: Do not stop taking Edistride without talking to your doctor first.
Estonian: Ärge lõpetage Edistride võtmist, enne kui olete sellest arstiga rääkinud.
English: Pharmacotherapeutic group: Drugs used in diabetes, Sodium-glucose co-transporter 2 (SGLT2) inhibitors, ATC code: A10BK01
Estonian: Farmakoterapeutiline rühm: diabeediravimid, naatriumi-glükoosi kotransporter 2 (SGLT-2) inhibiitorid, ATC-kood: A10BK01
English: This finding was consistent across subgroups.
Estonian: See tulemus oli ühetaoline kõigis alarühmades.
English: If you suspect you have diabetic ketoacidosis, contact a doctor or the nearest hospital straight away and do not take this medicine.
Estonian: Kui kahtlustate, et teil võib olla diabeetiline ketoatsidoos, võtke kohe ühendust oma arstiga või pöörduge lähimasse haiglasse ja ärge võtke enam seda ravimit.